Amyloidosis is a rare infiltrative condition resulting from the extracellular accumulation of amyloid fibrils at the cardiac level. It can be an acquired condition or due to genetic mutations. With the progression of imaging technologies, a non-invasive diagnosis was proposed. In this study, we discuss the role of CMR in cardiac amyloidosis, focusing on the two most common subtypes (AL and ATTR), waiting for evidence-based guidelines to be published.
Keywords: T1 mapping; T2 mapping; cardiac amyloidosis (CA); cardiovascular magnetic resonance (CMR); extracellular volume (ECV); late gadolinium enhancement (LGE).